Xiaflex Clinical Trials Show Promising Results for Peyronies Disease
The first Phase II trials, sponsored and monitored by BioSpecifics Technologies Corp , licensor of Xiaflex have been conducted. The follow up along with data analysis has been conducted by Auxilium and it has shown very promising results in the treatment of Peyronie’s Disease. So much so, that the trials have now move onto Phase III.
View full press release